Journals / MN Oftalmoloji / 2016 / Cilt: 23 - Sayı: 1

Blood-Derived Tear Substitutes

Kan Ürünü Gözyaşı Takviyeleri

Pages
40–47
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review discusses the current blood-derived tear substitute options, including blood serum, plasma, umbilical cord serum, platelet concentrates and albumin, andbriefly describes the epitheliotropic factors that make these options valuable as tear substitutes

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The unique composition of natural tears is essential for ocular surface homeostasis.
📊
Key Findings & Data:Tear deficiency deteriorates the tissueintegrity of the cornea and conjunctiva, natural immunity towards infections, and the clear vision provided by smooth opticalsurfaces.
💡
Conclusion & Impact:This review discusses the current blood-derived tear substitute options, including blood serum, plasma, umbilical cord serum, platelet concentrates and albumin, andbriefly describes the epitheliotropic factors that make these options valuable as tear substitutes
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The unique composition of natural tears is essential for ocular surface homeostasis. Tear deficiency deteriorates the tissueintegrity of the cornea and conjunctiva, natural immunity towards infections, and the clear vision provided by smooth opticalsurfaces. Furthermore, due to the high density of free nerve endings in the corneal surface, tear deficiency negatively affectslife quality with each blink. This rich fluid has not yet to be matched by artificial alternatives; fortunately, other natural, richbodily fluids can be derived from the blood and used in its stead. Although not represented in the medical literature, the recovery of eye health through the application of blood serum to the ocular surface was first described six centuries ago inwritten literature, in the Tale of Bamsi Beyrek, a story contained in the Book of Dede Korkut. The topic of blood-derived fluids as ophthalmic therapy has gained interest to modern medicine since 1999. This review discusses the current blood-derived tear substitute options, including blood serum, plasma, umbilical cord serum, platelet concentrates and albumin, andbriefly describes the epitheliotropic factors that make these options valuable as tear substitutes

Özet

Doğal gözyaşının eşsiz içeriği, oküler yüzey homeostazisi için vazgeçilmezdir. Gözyaşı eksikliği, kornea ve konjonktiva epiteliyle başlayan doku bütünlüğünü, enfeksiyonlara yönelik doğal direnci, optik pürüzsüzlükle sağlanan net görmeyi bozar.Ayrıca, serbest sinir ucu yoğunluğu nedeniyle her göz kırpmada yaşam kalitesini de olumsuz yönde etkiler. Yapay alternatifibulunmayan bu zengin içerikli sıvı, ne mutlu ki, bir başka zengin içerikli doğal vücut sıvısı olan kan kökenli sıvılarla yerinekonabilecek durumdadır. Tıp literatüründe yer almasa da, yazılı literatüre geçmiş olan ve 6 asır önce kaleme alınmış DedeKorkut Kitabı'ndaki Bamsı Beyrek Öyküsü'nde ilk kez tarif edilen kan serumunun göz yüzeyine uygulanması yoluyla göz sağlığının yeniden kazanılması, modern tıbbın özellikle 1999'dan sonra çokça üzerinde durduğu bir başlık olmuştur. Bu derlemede, kan serumu başta olmak üzere, plazma, kordon kanı serumu, trombosit konsantreleri ve albümin kan ürünü gözyaşıtakviyesi seçenekleri olarak ele alınmış, onları zengin kılan epitelyotrofik faktörler kısaca tanıtılmıştır

🔖

Cite This Article

EĞRİLMEZ, S. (2016). Blood-Derived Tear Substitutes. MN Oftalmoloji, Cilt: 23 - Sayı: 1, 40–47. https://ajindex.com/articles/295546

References (17)

  1. Egrilmez S, Ekici M, Gozen O. First serum treatment of ocular surface disease in written literature. J Ocul Pharmacol Ther 2013;29:288-9
  2. Egrilmez S. Sjögren Sendromunda Göz Bulguları ve Tedavisi. T Klin J Immunol Rheumatol 2008;1:15-21
  3. Ralph RA, Doane MG, Dohlman CH. Clinical experi- ence with a mobile ocular perfusion pump. Arch Ophthalmol 1975;93:1039-43
  4. Fox RI, Chan R, Michelson JB, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984;27:459-61
  5. Fukuda M, Fullard RJ, Willcox MD, et al. Fibronectin in the tear film. Invest Ophthalmol Vis Sci 1996;37:459- 67
  6. Nishida T. The role of fibronectin in corneal wound healing explored by a physician-scientist. Jpn J Ophthalmol 2012;56:417-31
  7. Bradley JC, Simoni J, Bradley RH, McCartney DL, Brown SM. Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops. Cornea 2009;28:200-5
  8. Song QH, Klepeis VE, Nugent MA, Trinkaus-Randall V. TGF-beta1 regulates TGF-beta1 and FGF-2 mRNA expression during fibroblast wound healing. Mol Pathol 2002;55:164-76
  9. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000;19:113-29
  10. Welge-Lussen U, May CA, Neubauer AS, Priglinger S. Role of tissue growth factors in aqueous humor homeostasis. Curr Opin Ophthalmol 2001;12:94-9
  11. Goyal S, Hamrah P. Understanding Neuropathic Corneal Pain-Gaps and Current Therapeutic Approaches. Semin Ophthalmol 2016;31:59-70
  12. Lambiase A, Rama P, Bonini S, Caprioglio G, Aloe L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 1998;338:1174-80
  13. Kruse FE, Tseng SC. Growth factors modulate clonal growth and differentiation of cultured rabbit limbal and corneal epithelium. Invest Ophthalmol Vis Sci 1993;34:1963-76
  14. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467-74
  15. Pan Q, Angelina A, Zambrano A, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev 2013;8:CD009327
  16. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin 2000;40:113-22
  17. Wilson SE, Liang Q, Kim WJ. Lacrimal gland HGF, KGF, and EGF mRNA levels increase after corneal epithelial wounding